March 31, 2022 Atomic Spectroscopy Product Launch

HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology

MENLO PARK, Calif., March 31, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, announced today PacBio’s essential contribution to the completion of the first truly complete human reference genome. The Telomere-to-Telomere (T2T) Consortium, an international team of scientists from the US National Human Genome Research Institute and... Read more

March 31, 2022 Clinical Research/Diagn. Microscopy Product Launch

GE Healthcare and Leading Korean Hospital Aim to Accelerate AI Ecosystem Using GE’s New Edison Digital Health Platform

Seoul National University Bundang Hospital to leverage GE Healthcare’s artificial intelligence (AI) capabilities to take the lead in using medical AI in their hospital system. The two collaborators intend to support and accelerate Korean start-ups to test and develop clinical applications on Edison Digital Health Platform Seoul, South Korea – March 31, 2022 — GE... Read more

March 28, 2022 Atomic Spectroscopy

Using Zebrafish to Spark Student Interest in Science

BioEYES is a K-12 science education program that caught our attention with its use of classroom microscopes to visualize its primary teaching tool, zebrafish. We were further impressed to learn this organization has served over 155,000 students in thirteen global locations. ZEISS had recently donated a ZEISS Stemi 305 stereo microscope to the Philadelphia, USA,... Read more

March 23, 2022 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

GE Healthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical

First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care Builds on market leadership with SPECT agent DaTscan™ (Ioflupane I 123 Injection), to... Read more

March 23, 2022 Uncategorized

PacBio Opens European Headquarters in London

Company Announces New European Headquarters to Serve Growing Customer Demand in Europe, Middle East and Africa Region Also Announces First Commercial Services Provider in Europe MENLO PARK, Calif., March 23, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, today announced the company’s expansion to better serve customers... Read more